Thermosensitive poly(organophosphazene)–paclitaxel conjugate gels for antitumor applications
Source abstract
Abstract
A poly(organophosphazene)-PTX conjugate was synthesized by a covalent ester linkage between PTX and carboxylic acid-terminated poly(organophosphazene), which can be readily modified by various hydrophobic, hydrophilic, and other functional substitutes. The physicochemical properties, hydrolytic degradation and PTX release behaviors of the polymer-PTX conjugate were characterized, in addition to the in vitro and in vivo antitumor activities. The aqueous solutions of these conjugates showed a sol-gel transition behavior that depended on temperature changes. The in vitro antitumor activity of the polymer-PTX conjugate was investigated by an MTT assay against human tumor cell lines. From the in vivo antitumor activity studies with tumor-induced (xenografted) nude mice, the polymer-paclitaxel conjugate hydrogels after local injection at the tumor site were shown to inhibit tumor growth more effectively and longer than paclitaxel and saline alone, indicating that the tumor-active paclitaxel from the polymer-PTX conjugate hydrogel is released slowly over a longer period of time and effectively accumulated locally in the tumor sites. These combined observations suggest that this poly(organophosphazene)-PTX conjugate holds promise for use in clinical studies as single and/or combination therapies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Drug-targeting strategies in cancer therapy10.1016/S0959-437X(00)00164-7 ↗
2. Advancing the field of drug delivery: taking aim at cancer10.1016/S1535-6108(03)00276-9 ↗
3. Polymer conjugates as anticancer nanomedicines10.1038/nrc1958 ↗
4. The taxanes: an update10.1016/S0140-6736(00)02074-2 ↗
5. Nanoparticle and targeted systems for cancer therapy10.1016/j.addr.2004.02.014 ↗
6. Pharmaceutical aspects of paclitaxel10.1016/S0378-5173(98)00188-4 ↗
7. Paclitaxel – a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer10.2165/00003495-199448050-00009 ↗
8. Paclitaxel and its formulations10.1016/S0378-5173(01)00986-3 ↗
9. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel10.1016/S0939-6411(03)00095-X ↗
10. Controlled release of paclitaxel from biodegradable unsaturated poly(ester amide)/poly(ethylene glycol) diacrylate hydrogels10.1163/156856207780852569 ↗
11. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel10.1016/j.ijpharm.2006.09.027 ↗
12. New biodegradable polymers for injectable drug delivery systems10.1016/S0168-3659(99)00061-9 ↗
13. Pendent drugs, release from polymers
14. Drug delivery systems: water soluble taxol 2′-poly(ethylene glycol) ester prodrug – design and in vivo effectiveness10.1021/jm950475e ↗
15. Complete regression of well-established tumors using a novel water-soluble poly(l-glutamic acid)–paclitaxel conjugate
16. Phase I and pharmacokinetics study of PNU166945, a polymer formulated paclitaxel
17. Phase I clinical and pharmacokinetic study of PNU 166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel10.1097/00001813-200104000-00003 ↗
18. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer10.1016/j.coph.2006.01.009 ↗
19. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review10.1016/S0168-3659(99)00248-5 ↗
20. A new class of biodegradable thermosensitive polymers. 1. Synthesis and characterization of poly(organophosphazenes) with methoxy-poly(ethylene glycol) and amino acid esters as side groups10.1021/ma981190p ↗
21. A new class of biodegradable thermosensitive polymers. 2. Hydrolytic properties and salt effect on the lower critical solution temperature of poly(oragnophosphazenes) with methoxypoly(ethylene glycol) and amino acid esters as side groups10.1021/ma990645n ↗
22. Synthesis and characterization of biodegradable thermosensitive poly(organophosphazene) gels10.1021/ma0305838 ↗
23. Synthesis and biocompatibility of thermosensitive poly(organophosphazene) gels
24. Biodegradable polyphosphazenes for drug delivery applications10.1016/S0169-409X(03)00039-5 ↗
25. Biodegradable polyphosphazenes for biomedical applications
26. Synthesis and properties of low molecular weight polyphosphazene10.1021/ma00126a039 ↗
27. Chemistry of the amino acids
28. Song S-C, Lee S-M, Kim C-W. Thermosensitive polyphosphazene–bioactive molecule conjugates, preparation method thereof and use thereof. WO 2007114549; 2007.
29. Self-assembly in aqueous solutions of poly(ethylene oxide)-b-poly(ethylene oxide)-b-poly(vinyl alcohol)10.1021/la990946q ↗
30. Synthesis and characterization of the paclitaxel/MPEG–PLA block copolymer conjugate10.1016/j.biomaterials.2004.06.024 ↗
31. Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug10.1016/j.ejpb.2004.02.012 ↗
32. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity10.1021/jm00124a011 ↗
33. Poly[(amino acid ester)phosphazenes]: synthesis, crystallinity, and hydrolytic sensitive in solution and the solid state10.1021/ma00083a001 ↗
34. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases10.1007/s00280-006-0296-4 ↗
35. Polymers containing enzymatically degradable bonds, 7. Design of oligopeptide side chains in poly[N-(2-hydroxypropyl)methacrylamide] copolymers to promote efficient degradation by lysosomal enzymes10.1002/macp.1983.021841005 ↗
36. The lysosome/endosome membrane: a barrier to polymer-based drug delivery10.1002/1521-3900(200107)172:1<29::AID-MASY29>3.0.CO;2-1 ↗
37. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line10.1016/S0168-3659(98)00009-1 ↗
38. Synthesis and evaluation of water-soluble paclitaxel prodrugs10.1016/S0960-894X(02)00694-7 ↗